2 drug(s) with this reaction
1,412 total reports
Application Site Rash has been reported as an adverse reaction across 2 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,412 adverse event reports mention application site rash in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with application site rash, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have application site rash listed in their FDA adverse event reports, sorted by report count:
In addition to application site rash, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
2 drug(s) manufactured by Haleon Us Holdings Llc have application site rash listed in their FDA adverse event reports: NICOTINE, NICOTINE POLACRILEX.
There are a combined 1,412 reports of application site rash across 2 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.